Updated:
Corin Group PLC
Corin Group PLC was established in 1985 in Cirencester, Gloucestershire, as a developer of orthopedic implants.
Corin Group PLC
Corin Group PLC was established in 1985 in Cirencester, Gloucestershire, as a developer of orthopedic implants. The firm is publicly traded on the London Stock Exchange's AIM market, with major shareholders including private equity firm 3i Group and other institutional investors, rather than a single family office. Corin designs, manufactures, and markets hip and knee replacement systems, including the OPS (Optimized Positioning System) for computer-assisted surgery and personalized implant alignment. Its product portfolio spans total hip arthroplasty, total knee arthroplasty, and revision surgery components. Distribution reaches over 40 countries across Europe, Asia Pacific, and the Americas, with direct operations in the UK, France, Germany, Australia, and the US. Corin holds a portfolio of over 200 patents. As of 2024, Corin employed approximately 1,000 people across its Cirencester headquarters and international offices. The company reported revenue of £243 million in 2023 (per public filings, 2023). In January 2024, Corin announced a strategic partnership with surgical robotics developer Think Surgical to integrate robotic assistance into its OPS workflow (per the firm, January 2024). Corin's structural differentiator is its focus on personalized, patient-specific orthopedic solutions via the OPS platform — a computer-assisted surgery system that uses preoperative CT scans to plan implant placement for each individual. Unlike larger competitors (e.g., Stryker, Zimmer Biomet), Corin concentrates exclusively on orthopedics with an integrated surgical planning and implant delivery model.
General information
Firm type
Asset Manager
Year founded
1985
AUM
Undisclosed
Location
Region
Europe
Country
United Kingdom
City
Cirencester
Corporate office
The Corinium Centre, Cirencester, Gloucestershire GL7 1YJ, United Kingdom
Sector focus
Frequently asked questions
Who founded Corin Group PLC and what is its ownership structure?
Corin Group was founded in 1985 by a group of orthopedic surgeons and engineers in Cirencester, UK. As of 2024, the company is publicly traded on the London Stock Exchange's AIM (Alternative Investment Market) under the ticker CRG. Major institutional shareholders include 3i Group (per public filings, 2023).
What are Corin's key product lines in orthopedics?
Corin focuses on hip and knee replacement systems, including the OPS (Optimized Positioning System) for computer-assisted surgery, which uses preoperative CT scans to plan patient-specific implant placement. The portfolio includes the Trinity knee system and the MiniHip hip system. Corin also offers revision surgery components.
In which markets does Corin operate and distribute?
Corin sells directly in the UK, France, Germany, Australia, and the United States, and distributes through partners in over 40 countries. Its primary markets include Europe, Asia Pacific, and the Americas. The US market accounted for a significant portion of revenue.
How does Corin differentiate its technology from larger orthopedic competitors?
Corin's OPS platform provides patient-specific surgical planning and implant alignment, using CT-based 3D modeling to customize implant positioning for each patient. This contrasts with larger competitors that often use standardized implant sizes and manual alignment tools for the majority of cases.
What recent partnerships has Corin announced in surgical robotics?
In January 2024, Corin announced a strategic collaboration with Think Surgical to integrate the TMINI Miniature Robotic System into its OPS workflow. This partnership aims to combine patient-specific planning with robotic assistance during surgery (per the firm, January 2024).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: